Klaus Schmierer
Queen Mary University of London
H-index: 52
Europe-United Kingdom
Top articles of Klaus Schmierer
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Prospective Longitudinal Study of Cladribine Tablets (CLADB Study) Demonstrates Sustained Reduction in Kappa Free Light Chains in Relapsing Multiple Sclerosis (RRMS) at 96 … | Francesca Ammoscato Justyna Skonieczna Jonathan Bestwick David Holden Mohammad Aboulwafa | 2024/4/14 | |
Comparing the Pathology, Clinical, and Demographic Characteristics of Younger and Older‐Onset Multiple Sclerosis | Annals of Neurology | Sarah Knowles Rod Middleton Benjamin Cooze Ildiko Farkas Yeung Yeung Leung | 2024/3 |
MS care: integrating advanced therapies and holistic management | Gavin Giovannoni Helen L Ford Klaus Schmierer Rod Middleton Andrea M Stennett | 2024/1/30 | |
Cladribine tablets in Relapsing-Remitting Multiple Sclerosis preferentially target B-cells | medRxiv | Francesca Ammoscato Mohammad Aboulwafa Justyna Skonieczna Jonathan p Bestwick Rosemary Monero | 2024 |
Decision Making About Disease-Modifying Treatments for Relapsing-Remitting Multiple Sclerosis: Stated Preferences and Real-World Choices | The Patient-Patient-Centered Outcomes Research | Edward JD Webb David Meads Ieva Eskytė Helen L Ford Hilary L Bekker | 2023/9 |
Investigation of Changes in Lymphocyte Subset Counts and their Relationship with MRI Outcomes in the Magnify-MS Study | Multiple Sclerosis and Related Disorders | Suzanne Hodgkinson Tobias Derfuss Finn Sellebjerg Patrick Vermersch Frederik Barkhof | 2023/12/1 |
A plain language summary of the impact of vaccines against flu and chickenpox in people with multiple sclerosis treated with cladribine tablets | Klaus Schmierer Heinz Wiendl Celia Oreja-Guevara Diego Centonze Anita Chudecka | 2023/2 | |
Organic solvents and Multiple Sclerosis: the doubled risk dilemma | Occupational Medicine | A Seaton D Baker AK Hedstrom L Alfredsson K Schmierer | 2023/8/1 |
Parakinesia Brachialis Oscitans in a Patient With a First Manifestation of Multiple Sclerosis | Neurology: Clinical Practice | Manuel Salavisa Bader Mohamed Kimberley Allen-Philbey Andrea M Stennett Thomas Campion | 2023/12 |
The impact of sphingosine-1-phosphate receptor modulators on COVID-19 and SARS-CoV-2 vaccination | David Baker Eugenia Forte Gareth Pryce Angray S Kang Louisa K James | 2023/1/1 | |
Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccination | Multiple Sclerosis Journal | Safiya A Zaloum Callum H Wood Pooja Tank Matthew Upcott Nicola Vickaryous | 2023/7 |
Disease activity 4.5 years after starting cladribine: experience in 264 patients with multiple sclerosis | Therapeutic Advances in Neurological Disorders | Kimberley Allen-Philbey Stefania De Trane Amy MacDougall Ashok Adams Lucia Bianchi | 2023/11 |
Efficacy in Clinical and MRI Outcomes With Cladribine Tablets Treatment in Highly Active Relapsing Multiple Sclerosis (MAGNIFY-MS) | 2023 Annual Meeting of the Consortium of Multiple Sclerosis Centers | Nicola De Stefano Anat Achiron Frederik Barkhof Andrew Chan Tobias Derfuss | 2023/6/1 |
Honing in on magnetic resonance imaging predictors of multiple sclerosis pathology | Brain Pathology | Klaus Schmierer | 2023/11 |
Anaesthetic management of people with multiple sclerosis | N Dubuisson O de Maere d'Aertrycke M Marta S Gnanapavan B Turner | 2023/10/11 | |
Blood Biomarker Dynamics in Highly Active Relapsing Multiple Sclerosis Patients Treated With Cladribine Tablets: Results of the 2-Year MAGNIFY-MS Study (S16. 006) | Heinz Wiendl Nicola De Stefano Frederik Barkhof Xavier Montalban Anat Achiron | 2023/4/25 | |
Neutropenia following immune-depletion, notably CD20 targeting, therapies in multiple sclerosis | Mult Scler Relat Disord | David Baker Angray S Kang Gavin Giovannoni Klaus Schmierer | 2023/12/22 |
Early Onset of Action and Sustained Efficacy of MRI Outcomes During Cladribine Tablets Treatment in Highly Active Relapsing Multiple Sclerosis: Results of the 2-year MAGNIFY-MS … | Nicola De Stefano Anat Achiron Frederik Barkhof Andrew Chan Tobias Derfuss | 2023/4/25 | |
The expression of active CD11b monocytes in blood and disease progression in amyotrophic lateral sclerosis | International Journal of Molecular Sciences | Ozlem Yildiz Johannes Schroth Vittoria Lombardi Valentina Pucino Yoana Bobeva | 2022/3/21 |
Factors contributing to CSF NfL reduction over time in people with multiple sclerosis starting treatment: an observational study | I Smets D Holden L Bianchi F Ammoscato K Allen-Philbey | 2022 |
Co-Authors
